Podcasts about fidsa

ID physicians Priya Nori, MD, FSHEA, FIDSA, and Gonzalo Bearman, MD, MPH, FACP, FSHEA, FIDSA, join Paul Sax, MD, FIDSA, to discuss challenges often faced by ID specialists, including gaslighting and uncompensated labor. The three discuss how physicians can advocate for themselves, set boundaries, and push for meaningful change within their institutions.Are We Being Gaslit? A Primer for Recognizing Corporate Jargon to Overcome Gaslighting for the Infectious Disease Workforce: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaf097/8056053Minimizing Low-Value, Uncompensated Work in Academic Infectious Diseases: A 6-Step Program: https://academic.oup.com/cid/article/78/6/1656/7610959

We've all heard of medical malpractice and its dire costs, but what about leadership malpractice? Should there be consequences or at least more resistance to those implementing non-evidence-based leadership tactics in academic medicine? Those questions and much more are explored in depth with our guest this week on the Faculty Factory Podcast, author Joshua Hartzell, MD, MS-HPEd, FACP, FIDSA, who joins us to discuss: Leadership responsibility and development Cultural strategies from the military that could be woven into academic health Excellence through empathy and compassion Utilizing delegation as a growth opportunity for others With 25 years in military medicine under his belt, Dr. Hartzell is a retired army colonel and a practicing internal medicine and infectious diseases physician. It's all about being more intentional with how we lead and taking care of people—that is what a healthy workplace culture rides on, according to this interview with Dr. Hartzell. "Most of the things we experience and our challenges are not clinical care issues. It's a leadership issue. We're really good at the clinical care part, but not so much the messy leadership stuff and how to deal with that," he said. Learn More Explore his book, "A Prescription for Caring in Healthcare Leadership: Building a Culture of Compassion and Excellence": https://www.amazon.com/Prescription-Caring-Healthcare-Leadership-Compassion/dp/B0DSQ4276K Visit Faculty Factory: https://facultyfactory.org/ 

Paul Sax, MD, FIDSA, is joined by infectious diseases physicians and international medical graduates, Vidya Sundareshan, MD, and Alfredo Mena Lora, MD, FIDSA, to discuss how international medical graduates (IMGs) can pursue a career in infectious diseases. The trio discuss visa options, job search strategies, and how political change could impact the process.

Paul Sax, MD, FIDSA, speaks with Adam Ratner, MD, MPH, Professor of Pediatrics and Microbiology at NYU Grossman School of Medicine and Director of the Division of Pediatric Infectious Diseases at Hassenfeld Children's Hospital and Bellevue Hospital Center, about his book, "Booster Shots: The Urgent Lessons of Measles" and the rise of vaccine preventable diseases. 

Anna Person, MD discusses threats to the Medicaid program and how they could impact people with HIV with Kate McManus, MD, MSc, FIDSA, Associate Professor of Medicine at the University of Virginia in the Division of Infectious Diseases and International Health and Amy Killelea, JD, Assistant Research Professor at the Georgetown University Center on Health Insurance Reforms (CHIR) and consultant to the HIV Medicine Association.  

Tuberculosis remains a pressing public health challenge, with recent outbreaks highlighting its persistent threat. In this episode infectious disease expert Dr. Matt Shoemaker dives into the TB outbreak in Kansas. He unpacks the complexities of its transmission, the symptoms to watch for, and the obstacles faced in controlling its spread. Explore how public health officials are tackling this crisis, the crucial role of identifying latent TB cases, and the broader influence of policy on prevention. Join us for an eye-opening discussion on combating this enduring health concern. Hosted by: Kelly Holmes, MS, CIC, FAPIC and Lerenza L. Howard, MHA, CIC, LSSGB About our Guest: Dr. Matt Shoemaker, DO, FIDSA Dr. Matt Shoemaker, DO, FIDSA, Infectious Disease and Internal Medicine, graduated from the University of Health Sciences-College of Osteopathic Medicine in Kansas City, MO in 2000. He subsequently completed a traditional rotating osteopathic internship at Capital Regional Medical Center in Jefferson City, MO. After completion of his internship, he completed a residency in Internal Medicine and a fellowship in Infectious Disease, both at the University of Missouri – Columbia School of Medicine in Columbia, MO. He also maintains a medical practice specializing in Infectious Disease. Dr. Shoemaker is certified by the American Board of Internal Medicine in Infectious Diseases and Internal Medicine. He was in private practice in southeast Missouri from 2006 until 2019. He also served as vice president and chief medical officer at SoutheastHEALTH in Cape Girardeau, MO from 2014 until 2019. In 2018 he was advanced to a Fellow of the Infectious Diseases Society of America. In July of 2019 he joined the University of Kansas Medical Center Division of Infectious Diseases as assistant professor of clinical medicine. He is currently an associate professor of clinic medicine and serves as the Director of the Division of Infectious Disease at the University of Kansas Medical Center.

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss: Workup of COVID-19 in the emergency departmentMethods of COVID-19 risk stratification Treatment recommendations for people with severe COVID-19, including how to effectively use antiviral therapy, dexamethasone, and other immunomodulators[CC1] in this population A detailed patient case to illustrate key takeawaysPresenters:Stephen Cantrill, MD, FACEP​Associate Director and Medical Director (Retired) ​ Department of Emergency Medicine​ Denver Health Medical Center​ Associate Professor ​ Department of Emergency Medicine​ University of Colorado Health Sciences Center​ Denver, Colorado Rajesh T. Gandhi, MD​Massachusetts General Hospital​ Professor of Medicine​ Harvard Medical School​ Boston, Massachusetts Payal K. Patel, MD, MPH, FIDSA​Systemwide Director of Antimicrobial Stewardship​ Associate Professor, Division of Infectious Diseases​ Intermountain Health​ Salt Lake City, Utah Link to full program: https://bit.ly/4gu2gcUGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss treatment strategies for people who have severe COVID-19, including: Antiviral therapy with remdesivir Dexamethasone and other systemic corticosteroids Immunomodulators, such as JAK inhibitors or IL-6 inhibitors Overviews of clinical trial data demonstrating how and when to use these therapiesPresenters:Stephen Cantrill, MD, FACEP​Associate Director and Medical Director (Retired) ​ Department of Emergency Medicine​ Denver Health Medical Center​ Associate Professor ​ Department of Emergency Medicine​ University of Colorado Health Sciences Center​ Denver, Colorado Rajesh T. Gandhi, MD​Massachusetts General Hospital​ Professor of Medicine​ Harvard Medical School​ Boston, Massachusetts Payal K. Patel, MD, MPH, FIDSA​Systemwide Director of Antimicrobial Stewardship​ Associate Professor, Division of Infectious Diseases​ Intermountain Health​ Salt Lake City, Utah Link to full program: https://bit.ly/4gu2gcUGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.    

IDSA Board Member Mati Hlatshwayo Davis, MD, MPH, FIDSA, discusses public health forecasting and response efforts with Lior Rennert, PhD, director of the Center for Public Health Modeling and Response at Clemson University, and Dylan George, PhD, director of CDC's Center for Forecasting and Outbreak Analytics (CFA). 

IDSA Board Member Mati Hlatshwayo Davis, MD, MPH, FIDSA, Former CDC Director Rochelle Walensky, MD, MPH, FIDSA, and VP of Health Programs at the Carter Center, Kashef Ijaz, MD, MPH, discuss the legacy of Former President Jimmy Carter, his work addressing neglected tropical diseases and the impact and value of public advocacy and political support for these diseases. 

Paul Sax, MD, FIDSA, is joined by Varun Phadke, MD, and Daniel Minter, MD, co-creators of CID's new series, "Clinical Dilemmas in Infectious Diseases," which guides readers through challenging clinical management decisions in infectious diseases.Click here to learn more about submitting to the Clinical Dilemmas in Infectious Diseases series.Click here to read the first Clinical Dilemmas in Infectious Diseases papers. 

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss current trends in and risk factors for progression to severe COVID-19, including for those for whom COVID-19 is not their primary concern when presenting to the emergency department (ED). Key topics of discussion include: How to complete a comprehensive patient workup in the EDConsiderations regarding pulse oximetryRisk stratification—what places patients at higher risk of severe disease?A detailed patient case to illustrate key takeawaysPresenters:Stephen Cantrill, MD, FACEP​Associate Director and Medical Director (Retired) ​Department of Emergency Medicine​Denver Health Medical Center​Associate Professor ​Department of Emergency Medicine​University of Colorado Health Sciences Center​Denver, ColoradoRajesh T. Gandhi, MD​Massachusetts General Hospital​Professor of Medicine​Harvard Medical School​Boston, MassachusettsPayal K. Patel, MD, MPH, FIDSA​Systemwide Director of Antimicrobial Stewardship​Associate Professor, Division of Infectious Diseases​Intermountain Health​Salt Lake City, UtahLink to full program:https://bit.ly/4fs7HcbGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP, discusses the 2024-2025 respiratory illness season with Brendan Jackson, MD, MPH, Director of the Office of Readiness, Response and Operations at the CDC National Center for Immunization and Respiratory Diseases.

In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics:Screening recommendationsStrategies to improve HCV screeningHCV testingTreatment goalsStrategies to improve HCV treatment uptakePresenters:Stacey B. Trooskin, MD, PhD, MPHExecutive Medical OfficerMazzoni CenterFaculty, University of PennsylvaniaPerelman School of MedicinePhiladelphia, PennsylvaniaMark S. Sulkowski, MD, FIDSA, FAASLDProfessor of MedicineDirector, Division of Infectious Diseases Johns Hopkins Bayview Medical CenterJohns Hopkins University School of MedicineBaltimore, MarylandRonni MarksFounder/Director, The Hepatitis C Mentor and Support Group (HCMSG)Patient AdvocateNew York, New YorkLink to full program:https://bit.ly/4grbwPT

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss best practices in treating patients hospitalized with mild to moderate COVID-19, including: Current guidelines from the Infectious Diseases Society of America and National Institutes of Health How to optimize therapy selection based on patient risk factors, including key data supporting best practicesA detailed patient case to illustrate key takeawaysPresenters:Stephen Cantrill, MD, FACEP​Associate Director and Medical Director (Retired) ​Department of Emergency Medicine​Denver Health Medical Center​Associate Professor ​Department of Emergency Medicine​University of Colorado Health Sciences Center​Denver, ColoradoRajesh T. Gandhi, MD​Massachusetts General Hospital​Professor of Medicine​Harvard Medical School​Boston, MassachusettsPayal K. Patel, MD, MPH, FIDSA​Systemwide Director of Antimicrobial Stewardship​Associate Professor, Division of Infectious Diseases​Intermountain Health​Salt Lake City, UtahLink to full program: https://bit.ly/4fs7HcbGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Saint Louis Story Stitchers youth artists created a Story Circle to share stories of the mental health crisis and solutions. Their guest was Dr. Matifadza (Mati) Hlatshwayo Davis, MD, MPH, FIDSA, Director of Health for the City of St. Louis. This episode was recorded on June 17, 2024 at Story Stitchers' Studio 1A, The Center, in the Grand Center Arts District, St. Louis, Missouri.   Pick the City UP Art Interlude Can You Tell? Saint Louis Story Stitchers, 2024   To learn more about mental health care in St. Louis or the Perception Isn't Always Reality project, visit storystitchers.org These Special Edition episodes of StitchCast Studio are the result of a partnership with YouthBridge Community Foundation through its Think Big For Kids grant. Story Stitchers project, Perception Isn't Always Reality, will create a public service announcement campaign as trusted messengers about mental health stigmas.  Story Stitchers creative youth development programs are supported in part by The Lewis Prize for Music's 2021 Accelerator Award. The mission of The Lewis Prize is to partner with leaders who create positive change by investing in young people through music.  Additional support for StitchCast Studio and Story Stitchers programs is provided by the Regional Arts Commission, the City of St. Louis Office of Violence Prevention in partnership with the St. Louis Board of Aldermen through the 2024-2025 Programs to Reduce Crime Among At-Risk Youth, and Tegna Foundation.  Saint Louis Story Stitchers' studio, The Center, is supported in part by Kranzberg Arts Foundation, where Story Stitchers is a proud resident organization.

Saint Louis Story Stitchers youth artists created a Story Circle to share stories of the mental health crisis and solutions. Their guest was Dr. Matifadza (Mati) Hlatshwayo Davis, MD, MPH, FIDSA, Director of Health for the City of St. Louis. This episode (Parts I & II) was recorded on June 17, 2024 at Story Stitchers' Studio 1A, The Center, in the Grand Center Arts District, St. Louis, Missouri.   Pick the City UP Art Interlude Victor Not Victim Saint Louis Story Stitchers, 2024   To learn more about mental health care in St. Louis or the Perception Isn't Always Reality project, visit storystitchers.org  These Special Edition episodes of StitchCast Studio are the result of a partnership with YouthBridge Community Foundation through its Think Big For Kids grant. Story Stitchers project, Perception Isn't Always Reality, will create a public service announcement campaign as trusted messengers about mental health stigmas.  Story Stitchers creative youth development programs are supported in part by The Lewis Prize for Music's 2021 Accelerator Award. The mission of The Lewis Prize is to partner with leaders who create positive change by investing in young people through music.  Additional support for StitchCast Studio and Story Stitchers programs is provided by the Regional Arts Commission, the City of St. Louis Office of Violence Prevention in partnership with the St. Louis Board of Aldermen through the 2024-2025 Programs to Reduce Crime Among At-Risk Youth, and Tegna Foundation.  Saint Louis Story Stitchers' studio, The Center, is supported in part by Kranzberg Arts Foundation, where Story Stitchers is a proud resident organization.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/CJB865. CME credit will be available until November 16, 2025.The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/CJB865. CME credit will be available until November 16, 2025.The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/CJB865. CME credit will be available until November 16, 2025.The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/CJB865. CME credit will be available until November 16, 2025.The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/CJB865. CME credit will be available until November 16, 2025.The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/CJB865. CME credit will be available until November 16, 2025.The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/CJB865. CME credit will be available until November 16, 2025.The Burden of RSV in Pediatric Populations: Evidence for Reshaping Care and Optimizing Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow

Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow

In this episode of HIV unmuted, host Juan Michael Porter II sits down with Jeanne Marrazzo, the Director of the National Institute of Allergy and Infectious Diseases (NIAID), in a conversation that goes beyond the headlines and deep into the heart of HIV research and advocacy. Dr Marrazzo, a leader with decades of experience in infectious disease research, shares her inspiring journey from her roots in Scranton, Pennsylvania, to her groundbreaking work in HIV prevention and care. Through this intimate conversation, listeners will discover what drives Dr. Marrazzo's commitment to equity, diversity and community-centered research, and how her personal and professional experiences shape her vision for the future of HIV science. From the challenges of addressing global health inequities to the optimism surrounding new HIV prevention methods, Dr Marrazzo offers valuable insights into the importance of inclusive messaging, the power of collaboration, and why putting people first remains at the core of her mission. Tune in to hear how Jeanne Marrazzo plans to navigate the evolving landscape of global health as she leads NIAID into a new era, and why she believes that hope, innovation, and community are key to overcoming the ongoing challenges in the HIV response. Meet our guest: Jeanne Marrazzo   Jeanne Marrazzo, MD, MPH, FACP, FIDSA, is the Director of NIAID at the U.S. National Institutes of Health (NIH), where she oversees a USD 6.3 billion budget that supports research to advance understanding, diagnosis and treatment of infectious, immunologic and allergic diseases. She was previously the C. Glenn Cobbs Endowed Chair and Director of Infectious Diseases at the University of Alabama at Birmingham Heersink School of Medicine. She is a Fellow of the American College of Physicians and the Infectious Diseases Society of America (IDSA), and was Treasurer of the IDSA from 2021 to 2023, having served on the board since 2018. She researches the vaginal microbiome, sexually transmitted infections and HIV pre-exposure prophylaxis. She has had leadership roles in the NIH HIV Prevention Trials Network and the Infectious Diseases Clinical Research Consortium. She was a leading voice in communicating science during the COVID-19 pandemic.   Meet our host: Juan Michael Porter II  Juan Michael Porter II is a health journalist, HIV advocate, culture critic, educator and the host of HIV unmuted, the IAS podcast. He is the Senior Editor of TheBody.com and TheBodyPro – and the first person openly living with HIV to hold the position. Juan Michael's reportage combines data dives, personal narratives and policy analyses to address the real-world consequences of ever-shifting legislation on people's health outcomes. He has written for the Public Broadcasting Service, SF Chronicle, Philadelphia Inquirer, Christian Science Monitor, NY Observer, TDF Stages, Playbill, American Theatre, Time Out NY, Queerty, Anti-Racism Daily, Positively Aware, Documentary Magazine, SYFY Wire, Scholastic and Dance Magazine. 

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/WHB865. CME/CE/AAPA credit will be available until September 24, 2025.Adjusting HIV Treatment for ART-Experienced People With HIV: Switching ART to Address Antiretroviral Resistance, Adverse Events, and Adherence Barriers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

2024 marks the 10th anniversary of the West African Ebola epidemic that took the lives of 11,000 people. In this episode, IDSA President Steven K. Schmitt, MD, FIDSA speaks with Arjun Srinivasan, MD, Deputy Director for Program Improvement in the Division of Healthcare Quality Promotion at the CDC, and Angela Hewlett, MD, MS, FIDSA, Professor in the Division of Infectious Diseases at the University of Nebraska and the George W. Orr MD and Linda Orr Chair in Health Security, about their experiences on the frontline.General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

HIV specialist and former punk rock musician, Eamonn Vitt, MD, joins Paul Sax MD, FIDSA, to discuss running a small private practice in NYC and his efforts to seek lower drug costs for his patients.General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

In this episode, Jennifer Cocohoba, PharmD, AAHIVP, and David Koren, PharmD, MPH, AAHIVP, FIDSA, cover the most impactful LA ART and LA PrEP clinical studies presented at AIDS 2024, including:The PURPOSE 1 study of twice-yearly lenacapavir injections vs daily oral tenofovir as PrEP in cisgender womenAn open-label extension of HPTN 084 evaluating LA CAB safety during pregnancy48-week data from the IMPAACT 2017/MOCHA study of LA CAB + RPV in adolescents with HIVA substudy of FLAIR evaluating the efficacy, safety, and tolerability of SC self-administration of LA CAB + RPV Presenters:Jennifer Cocohoba, PharmD, AAHIVPProfessor of Clinical PharmacyDepartment of Clinical PharmacyUniversity of California San Francisco School of PharmacySan Francisco, CaliforniaDavid Koren, PharmD, MPH, AAHIVP, FIDSAAdjunct Clinical ProfessorTemple University School of PharmacyClinical Pharmacist SpecialistTemple University Health SystemPhiladelphia, PennsylvaniaTo access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  See the full program here.

Anna Person, MD, FIDSA discusses opportunities to work with Medicaid managed care plans to optimize HIV care with Jenny Babcock, Senior Vice President for Medicaid Policy and Director of Strategic Operations at Association for Community Affiliated Plans and, Doug Wirth, President and CEO of Amida Care.Engaging Medicaid Managed Care Plans on HIV Access Helping Medicaid Patients Access Their HIV Medications Fact Sheet. General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

John Fangman, MD discusses how providers can engage with their state Medicaid programs to reduce barriers to HIV medications with Kate McManus, MD, MSc, FIDSA, Associate Professor of Medicine at the University of Virginia in the Division of Infectious Diseases and International Health and Ryan Westergaard, MD, PhD, MPH, Professor with the Division of Infectious Disease at the University of Wisconsin and Chief Medical Officer and State Epidemiologist for Communicable Diseases for the Wisconsin Department of Health Services. See the companion Helping Medicaid Patients Access Their HIV Medications Fact Sheet. 

Join us as Dr. Erica Johnson, Program Director at Johns Hopkins Bayview Medical Center, shares her experiences and best practices for recruitment and retention of a diverse medical workforce.   Following the residency's mission to reflect and serve the broader community guided her to build a residency program that stresses the importance of understanding the history of Baltimore and building trust within that community.  You'll hear tips to help diverse trainees thrive in a ``training program and be inspired to reflect on how to improve recruitment and retention practices in medical education. Website | Instagram | Twitter | Subscribe | Patreon | CME!| Youtube  thecurbsidersteach@gmail.com Show Segments Intro, disclaimer 01:08 Guest bio 02:10 Getting to Know Dr. Erica Johnson 05:50 Picks of the Week 08:23 Case from Kashlak 09:50 Recruitment to Reflect Community 12:40 Steward of the Mission: Dr. Johnson's Approach to Recruitment at Bayview Hopkins 15:33 Defining Diversity 17:29 Opportunities for Improvement in Recruitment 21:05 Leadership team's approach to highlighting mission and training setting 23:09 Resident Thriving 26:07 Individualized Mentorship 30:09 Holistic Review 32:45 Recruitment and Retention of Faculty 35:23 Importance and Examples of Pathway Programs 38:40 Selfless Service and Aligning Work with Mission 40:20 Importance of Program Director Community  42:48 Take Home Points 44:29 Outro Credits Producer, Show Notes, CME:  Era Kryzhanovskaya MD Infographic, Cover Art: Paige Spata MD Reviewer: Keith Dickerson, MD Hosts, Script, Editors: Era Kryzhanovskaya MD, Molly Heublein MD    Guest: Erica Johnson, MD Technical support: Podpaste Theme Music: MorsyMusic 

Anna Person, MD, FIDSA discusses Medicaid basics and how the program helps people with HIV with Lindsey Dawson, MPP, Associate Director of HIV Policy and Director of LGBTQT Health at KFF, and Wendy Armstrong, MD FIDSA, Professor of Medicine in the Division of Infectious Diseases and the Vice Chair of Education and Integration at the Emory University School of Medicine. See the companion fact sheet Understanding Why Medicaid Matters for People with HIV.

IDSA Board member Mati Hlatshwayo Davis, MD, MPH, FIDSA, discusses the importance of advocacy, including how IDSA and HIVMA members can get involved, with chair and vice chair of IDSA's advocacy captain subcommittee, Rachel Bender Ignacio, MD, MPH, FIDSA, and Kinna Thakarar, DO, MPH, FIDSA, as well as IDSA senior vice president of public policy and government relations, Amanda Jezek, and HIVMA executive director, Andrea Weddle. General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

As IDSA increases its involvement with state and regional ID societies, IDSA President Steven Schmitt, MD, FIDSA, discusses their value with Immediate Past President Daniel P. McQuillen, MD, FIDSA, President of the Michigan Infectious Diseases Society Anu Malani, MD, FIDSA, and Former President of the Texas ID Society Brad Cutrell, MD, FIDSA. General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G – an FDA authorized, antibiotic-eluting bone void filler. For more information, visit https://www.bonesupport.com/en-us/products/cerament-g/ Warren Joseph DPM, FIDSA moderates a conversation about osteomyelitis in the foot and ankle with Alan Block, DPM and Jason Mendivil, DPM. In it, they not only discuss CERAMENT G and it's uses, but antimicrobial stewardship, minimally invasive outpatient procedures, and the critical importance of preventing amputation.   Interested in staying in touch? Follow BONESUPPORT on LinkedIn https://www.linkedin.com/company/bonesupport-ab/

In this episode, Cristina Mussini, MD,and William R. Short, MD, MPH, FIDSA,discuss the potential role of ART in weight change among people living with HIV.Listen to their conversation on whether ART switch can lead to weight loss after weight gain and how to counsel people living with HIV on weight loss options, including lifestyle modifications and nonpharmacologic methods.PresentersCristina Mussini, MD​Director of Infectious Diseases Clinics​Professor of Infectious Diseases​University of Modena School of Medicine​Modena, ItalyWilliam R. Short, MD, MPH, FIDSA​Associate Director of the ​HIV Clinical Trials Unit​Associate Professor of Medicine​Division of Infectious Diseases​Perelman School of Medicine​University of Pennsylvania​Philadelphia, PennsylvaniaFollow along with the slides here.https://bit.ly/3RLdrETSee the full program here.https://bit.ly/450Ql2xGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast channel on Apple Podcasts, Google Podcasts, or Spotify.

ID physician Courtney Harris, MD, FACP, speaks to Paul Sax, MD, FIDSA, about her experience job hunting as an ID fellow and provides tips on how to find your dream job in infectious diseases.  

In this episode, Angela Branche, MD, FIDSA, and Jewel Mullen, MD, MPH, MPA, FACP, address commonly asked questions about the RSV vaccine, including:Considerations for vaccine eligibilityRecommendations for pregnant personsVaccine administration based on RSV seasonalityUse of the vaccine in persons receiving immunosuppressive medicationsSafety data (eg, risk of serious adverse events)Natural immunity of RSVVaccine cost and insurance coverageFaculty:Angela Branche, MD, FIDSAAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkJewel Mullen, MD, MPH, MPA, FACPAssociate Dean for Health EquityAssociate Professor of Population Health and Internal MedicineUniversity of Texas at Austin Dell Medical SchoolAustin, TexasContent based on a CME program supported by an educational grant from GlaxoSmithKline.Follow along with a downloadable slideset at:https://bit.ly/44vCnFuLink to full program: https://bit.ly/3WvSY9ZTo get access to all of our new podcasts, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Angela Branche, MD, FIDSA, explores the burden of RSV disease in older adults, including:RSV seasonality and disease burdenSymptoms and complications of RSV infectionOlder age as a key risk factor for severe RSV disease and complications (eg, pneumonia, hospitalization)Comorbidities associated with increased risk of RSV hospitalizationRSV hospitalization rates among different racial and ethnic minority groups and socioeconomic statuses Faculty:Angela Branche, MD, FIDSAAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkContent based on a CME program supported by an educational grant from GlaxoSmithKline.Follow along with a downloadable slideset at: https://bit.ly/44vCnFuLink to full program: https://bit.ly/3WvSY9ZTo get access to all of our new podcasts, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

On this episode of The ICHE Podcast, Editor-in-Chief, David Calfee, MD, MS is joined by Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, Jasmine R. Marcelin, MD, FACP, FIDSA, and Caitlin McGrath, MD, MS. Today's episode explores DEI in infection prevention and antimicrobial stewardship as our guests discuss their recent articles in ICHE and highlight ICHE's dedicated section on DEI. Listen as our guests discuss various health equity concepts and associated terminology, how they apply to HAI risk and AMR risk, important areas of focus for future research, and what we can do today to help mitigate current disparities and inequities. After listening, be sure to visit cambridge.org/iche to read the full articles featured in today's episode.

CID editor-in-chief Paul Sax, MD, FIDSA, speaks with ID physician Darcy Wooten, MD, FIDSA, about her piece in CID's Voices of ID series, "The Arrivals Gate at Heathrow Airport" and the parallel between rom coms and ID.